Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
164M
-
Number of holders
-
132
-
Total 13F shares, excl. options
-
80.3M
-
Shares change
-
+9.57M
-
Total reported value, excl. options
-
$852M
-
Value change
-
+$94.5M
-
Put/Call ratio
-
0.93
-
Number of buys
-
74
-
Number of sells
-
-44
-
Price
-
$10.60
Significant Holders of Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA) as of Q4 2024
175 filings reported holding NMRA - Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value as of Q4 2024.
Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA) has 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 80.3M shares
of 164M outstanding shares and own 48.97% of the company stock.
Largest 10 shareholders include FMR LLC (7.84M shares), BlackRock, Inc. (7.11M shares), SOFTBANK GROUP CORP. (6.54M shares), T. Rowe Price Investment Management, Inc. (5M shares), VANGUARD GROUP INC (4.57M shares), MIC Capital Management UK LLP (4.46M shares), Siren, L.L.C. (4.4M shares), Deep Track Capital, LP (4M shares), Capital International Investors (3.7M shares), and WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST (3.31M shares).
This table shows the top 132 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.